Related Experiment Video
Updated: Aug 4, 2025

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
Published on: April 5, 2024
The Impact of the COVID-19 Pandemic on a Dedicated Vascular Emergency Clinic
Sarah Jane Messeder1, Imelda Black2, Andrew T O Nickinson3
1Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; Leicester Vascular Institute, University Hospitals of Leicester NHS Trust, Leicester, UK.
Insights
Vascular Emergency Clinics (VEC) maintained rapid treatment timelines for chronic limb-threatening ischemia (CLTI) patients during the COVID-19 pandemic. This study shows the VEC model
Area of Science:
- Vascular Surgery
- Public Health
- Epidemiology
Background:
- Vascular Emergency Clinics (VEC) offer a streamlined approach to managing chronic limb-threatening ischemia (CLTI).
- The COVID-19 pandemic presented unprecedented challenges to healthcare systems globally.
- Assessing the operational resilience of specialized clinics like VECs is crucial for maintaining patient care during public health crises.
Purpose of the Study:
- To evaluate the resilience and effectiveness of the outpatient Vascular Emergency Clinic (VEC) model during the initial year of the COVID-19 pandemic.
- To determine if rapid treatment timelines for patients with chronic limb-threatening ischemia (CLTI) were maintained despite pandemic-related disruptions.
- To analyze patient outcomes and treatment strategies within the VEC framework under pandemic conditions.
Main Methods:
- A retrospective analysis of a prospectively maintained database of patients assessed in a VEC from March 2020 to April 2021.
- Cross-referencing VEC data with national and regional COVID-19 data to contextualize operational challenges.
- Detailed analysis of patients diagnosed with CLTI, including assessment of Peripheral Arterial Disease-Quality Improvement Framework compliance and treatment pathways.
Main Results:
- The VEC model demonstrated resilience, with a median referral to assessment time of 3 days for CLTI patients.
- For non-admitted CLTI patients, median assessment to intervention was 8 days, and referral to intervention was 11 days.
- Outcomes included a 10.9% major lower limb amputation rate and a 25.8% mortality rate at 12 months, with 58.6% undergoing a first revascularization strategy.
Conclusions:
- The Vascular Emergency Clinic (VEC) model proved highly resilient to the challenges posed by the COVID-19 pandemic.
- Rapid treatment timelines essential for managing chronic limb-threatening ischemia (CLTI) were successfully maintained.
- The VEC's open-access, single-point-of-entry system facilitated continued effective patient care during the public health crisis.
Background:
Vascular Emergency Clinics (VEC) improve patient outcomes in chronic limb-threatening ischemia (CLTI). They provide a "1 stop" open access policy, whereby "suspicion of CLTI" by a healthcare professional or patient leads to a direct review. We assessed the resilience of the outpatient VEC model to the first year of the coronavirus disease (COVID-19) pandemic.
Methods:
A retrospective review of a prospectively maintained database of all patients assessed in our VEC for lower limb pathologies between March 2020 and April 2021 was performed. This was cross-referenced to national and loco-regional Governmental COVID-19 data. Individuals with CLTI were further analysed to determine Peripheral Arterial Disease-Quality Improvement Framework compliance.
Results:
Seven hundred and ninety one patients attended for 1,084 assessments (Male n = 484, 61%; Age 72.5 ± standard deviation 12.2 years; White British n = 645, 81.7%). In total, 322 patients were diagnosed with CLTI (40.7%). A total of 188 individuals (58.6%) underwent a first revascularization strategy (Endovascular n = 128, 39.8%; Hybrid n = 41, 12.7%; Open surgery n = 19, 5.9%; Conservative n = 134, 41.6%). Major lower limb amputation rate was 10.9% (n = 35) and mortality rate was 25.8% (n = 83) at 12 months of follow-up. Median referral to assessment time was 3 days (interquartile range: 1-5). For the nonadmitted patient with CLTI, the median assessment to intervention was 8 days (interquartile range: 6-15) and median referral to intervention time of 11 days (11-18).
Conclusions:
The VEC model has demonstrated strong resilience to the COVID-19 pandemic with rapid treatment timelines maintained for patients with CLTI.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Introduction Cardiac Emergencies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care